Compare SGHC & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHC | XENE |
|---|---|---|
| Founded | 2020 | 1996 |
| Country | Guernsey | Canada |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.7B |
| IPO Year | 2021 | 2014 |
| Metric | SGHC | XENE |
|---|---|---|
| Price | $12.68 | $39.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | $17.33 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 2.3M | 589.1K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $16.09 | N/A |
| Revenue Next Year | $9.73 | $2,496.48 |
| P/E Ratio | $20.80 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.46 | $35.97 |
| 52 Week High | $15.86 | $72.66 |
| Indicator | SGHC | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 33.95 | 14.04 |
| Support Level | $12.46 | N/A |
| Resistance Level | $13.02 | $45.39 |
| Average True Range (ATR) | 0.41 | 1.80 |
| MACD | -0.11 | -1.31 |
| Stochastic Oscillator | 10.95 | 2.10 |
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's four operating segments-Betway, Spin, Jumpman and DGC. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.